Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05526898 · ClinicalTrials.gov registry record · NA

Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Knee Osteoarthritis

A NA study of Knee Osteoarthritis, sponsored by Syntr Health Technologies.

Recruiting
Registry status
NA
Development phase
176
Enrollment target
2
Study locations

NCT05526898 is a NA study of Knee Osteoarthritis that is actively recruiting participants, run by Syntr Health Technologies. The registered enrollment target is 176 participants, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (42% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05526898, a NA study of Knee Osteoarthritis, is actively recruiting participants, sponsored by Syntr Health Technologies.

RECRUITING
Registry status
NA
Development phase
176 participants
Enrollment target
2
Study locations

Study Summary

This is an multi-center study with the aim of evaluating the efficacy of adipose tissue processed with the SyntrFuge™ system in Orthopedic Surgery, specifically Knee Osteoarthritis. Patients will be enrolled to the treatment group with adipose tissue processed with the SyntrFuge™ system followed by an injection of autologous microsized adipose tissue in the treatment sites or Standard of Care.

Conditions Studied

Interventions

  • DEVICE SyntrFuge System
  • DRUG Triamcinolone Injection

Study Locations (2)

California

  • Irvine Site 1 - Irvine
  • Irvine Site 2 - Irvine

Trial Details

FieldValue
Enrollment Target 176 participants
Start Date 2024-10-01
Est. Completion 2025-12
Phase NA

Sponsor

Syntr Health Technologies

3 total trials

What the Registry Record Tells You About NCT05526898

The ClinicalTrials.gov registry entry for NCT05526898 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 303-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (42% lower). The listed sponsor is Syntr Health Technologies, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Knee Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which SyntrFuge System is the first listed.

NCT05526898 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05526898 about?

NCT05526898 is a clinical study titled "Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Knee Osteoarthritis". This is an multi-center study with the aim of evaluating the efficacy of adipose tissue processed with the SyntrFuge™ system in Orthopedic Surgery, specifically Knee Osteoarthritis. Patients will be enrolled to the treatment group with adipose tissue processed with the SyntrFuge™ system followed by ...

What is the current status of trial NCT05526898?

This trial is currently recruiting. It is a NA study. The enrollment target is 176 participants. The study started on 2024-10-01. Estimated completion is 2025-12.

What conditions does trial NCT05526898 study?

This clinical trial studies the following conditions: Knee Osteoarthritis.

What interventions are being tested in trial NCT05526898?

The interventions under investigation include: SyntrFuge System (DEVICE), Triamcinolone Injection (DRUG).

Who is sponsoring clinical trial NCT05526898?

This trial is sponsored by Syntr Health Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05526898 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.